Insights Widest with the analysis, Proactive gives perspectives that others don't.

cannabis plants Zoetic International makes rapid progress with CBD business

Zoetic grows its own hemp and sells CBD products in the US and the UK

3 days, 9 hours ago
Deep dive

CardieX looks to expand into clinical and consumer markets

The company’s devices, technologies and digital solutions enable better management of global...

2 weeks, 1 day ago

Oneview’s cloud solution in response to the coronavirus protects clinicians...

The Irish medtech company’s ‘Oneview Cloud for COVID-19’ solution is being used by hospitals in...

on 2/5/20
Deep dive

Pharmaxis eyes partner funding for LOXL2 inhibitor program; CEO to present...

The company completed both its phase 1b trial of its systemic pan‐LOX inhibitor and a further...

on 30/4/20
Deep dive

Paradigm Biopharmaceuticals completes Zilosul dosing under FDA’s Expanded...

Earlier this month, Paradigm reported a 45% mean reduction in pain score across 34 patients with...

on 30/4/20


Orthocell preparing for launch in the US for its CelGro® bone regeneration...

Orthocell Ltd's (ASX:OCC) Paul Anderson speaks to Proactive's Andrew Scott following the news they've completed a submission to the US Food and Drug Administration (FDA) seeking 510(k) clearance for marketing its CelGro® product for dental guided bone and soft tissue regeneration...

6 days, 14 hours ago

Join Proactive

Get ahead of the curve

First with the equities news

Get our market previews and stories before the main networks.

Widest with the analysis

Not just the FTSE. Read about
opportunities from the whole
equities market.

Closest to the source

Hear directors at first-hand
or meet them in person at our events.

In at the start

Watch IPOs and access on the same terms as the institutions.